Heart Test Laboratories (NASDAQ:HSCSW) versus Avanos Medical (NYSE:AVNS) Head-To-Head Comparison

Heart Test Laboratories (NASDAQ:HSCSW) and Avanos Medical (NYSE:AVNS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations and risk.

Profitability

This table compares Heart Test Laboratories and Avanos Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	N/A	N/A
Avanos Medical	-7.39%	5.22%	3.81%

Analyst Recommendations

This is a summary of recent ratings and target prices for Heart Test Laboratories and Avanos Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0	0	0	0	N/A
Avanos Medical	1	1	1	0	2.00

Avanos Medical has a consensus price target of $29.50, indicating a potential upside of 37.79%. Given Avanos Medical’s higher probable upside, analysts plainly believe Avanos Medical is more favorable than Heart Test Laboratories.

Valuation and Earnings

This table compares Heart Test Laboratories and Avanos Medical’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	$1,950.00	N/A	N/A	N/A	N/A
Avanos Medical	$820.00 million	1.21	$50.50 million	($1.19)	-17.99

Avanos Medical has higher revenue and earnings than Heart Test Laboratories.

Insider and Institutional Ownership

93.8% of Avanos Medical shares are owned by institutional investors. 2.9% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Avanos Medical beats Heart Test Laboratories on 7 of the 8 factors compared between the two stocks.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

About Avanos Medical

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.